SSC, DIFFUSE SCLEROSIS

Clinical trials for SSC, DIFFUSE SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new SSC, DIFFUSE SCLEROSIS trials appear

Sign up with your email to follow new studies for SSC, DIFFUSE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human tests begin for promising new autoimmune disease drug

Disease control Recruiting now

This early-stage study is testing a new drug called SAR448501 in adults with moderate-to-severe lupus or rheumatoid arthritis who haven't gotten enough relief from their current treatments. The main goal is to find safe dose levels and see how the drug behaves in the body. About …

Matched conditions: SSC, DIFFUSE SCLEROSIS

Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

SSC, DIFFUSE SCLEROSIS

Get alerted when new SSC, DIFFUSE SCLEROSIS trials appear

First human tests begin for promising new autoimmune disease drug